QMS Medical Allied Services Limited (NSE: QMSMEDI) is a Mumbai, Maharashtra-based company in the Medical Testing, Analyzing, and Diagnostic Equipment industry. With a market capitalisation of ₹330 Cr, it ranks #2,273 by market cap among the 6,197 Indian listed companies on FinBizNet, and #4 of 7 in Medical Testing, Analyzing, and Diagnostic Equipment. At ₹170.50 (as of 19 Nov 2026), the share price is 21.4% below its 52-week high of ₹216.79 and 147.3% above its 52-week low of ₹68.95. The share price is up 80.0% over one year and up 27.0% over three months.
| Current Price | ₹170.50 |
|---|---|
| Market Cap | ₹330 Cr |
| NSE Symbol | QMSMEDI |
| Sector | Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies |
| Sub-Industry | Health Care Equipment > Medical Testing, Analyzing, and Diagnostic Equipment |
| P/E Ratio | 32.4 |
| Return on Equity | 12.29% |
| Return on Assets | 6.82% |
| 52-Week Range | ₹68.95 – ₹216.79 |
| 1-Year Price Change | +80.0% |
| 3-Month Price Change | +27.0% |
| Beta (1Y) | 0.73 |
| Dividend Yield | 0.29% |
| Headquarters | Mumbai, Maharashtra |
| Website | qmsmas.com |
| Revenue | ₹53 Cr |
|---|---|
| Net Profit | ₹2 Cr |
| Net Margin | 4.6% |
| EPS (Basic) | ₹1.26 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
QMS Medical Allied Services Limited reported revenue of ₹53 Cr in Q2 FY27, up 17.5% from ₹45 Cr in Q2 FY26 and down 7.6% from ₹57 Cr in Q1 FY27. It posted a net profit of ₹2 Cr for the quarter, against a net profit of ₹0 Cr in Q2 FY26 (up 481.0%). Across the 6 quarters from Q1 FY26 to Q2 FY27, quarterly revenue ranged from ₹37 Cr (Q3 FY26) to ₹57 Cr (Q1 FY27). The company was profitable in each of these 6 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹53 Cr | ₹2 Cr | 4.6% |
| Q1 FY27 | ₹57 Cr | ₹4 Cr | 7.0% |
| Q4 FY26 | ₹44 Cr | ₹2 Cr | 4.5% |
| Q3 FY26 | ₹37 Cr | ₹3 Cr | 8.5% |
| Q2 FY26 | ₹45 Cr | ₹0 Cr | 0.9% |
| Q1 FY26 | ₹47 Cr | ₹6 Cr | 13.6% |
Consolidated figures (₹ crore, XBRL filings).
Promoters held 68.11% of QMS Medical Allied Services Limited's shares as of Sept 2026, against 68.07% in Sept 2025 (+0.04 percentage points).
QMS Medical Allied Services Limited distributes medical and healthcare devices in India. The company also manufactures and sells glucometers, pulse oximeters, IR thermometers, BP monitors, anatomy sets, neurology kits, orthopedic aids, and weighing scales, etc.; and operates QMSMEDS, an e-commerce platform that sells healthcare devices of various brands. In addition, the company provides diagnostic and patient management services, including ambulatory blood pressure tracking, continuous blood glucose and blood pressure/glucose monitoring, tonometry, and HbA1C services. Further, it offers Educamedics, which provides customized scientific content in the form of conferences, online courses, webinars, recorded lectures, and others. Additionally, the company offers chemical and chemical products, pharmaceuticals, and medicinal chemical and botanical products. QMS Medical Allied Services Limited was founded in 1994 and is based in Mumbai, India.
1. Healthcare Equipments/Supplies & Services-This segment offers healthcare equipment and services. 2. Education-This segment engages in education business. 3. Camp-NA 4. B2B Sales Pharma Others-This segment engages in the sale of pharmaceuticals.
1. Healthcare Equipments/Supplies & Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Molbio Diagnostics Limited | ₹15,196 Cr | 94.7 | — | ₹259 Cr | — |
| Hemant Surgical Industries Lim | ₹939 Cr | 43.4 | — | — | +102.0% |
| Credent Connect N Care | ₹792 Cr | 31 | — | — | — |
| QMS Medical Allied Services Limited | ₹330 Cr | 32.4 | 12.29% | ₹53 Cr | +80.0% |
| Nureca Ltd | ₹290 Cr | 143.7 | 1.11% | ₹59 Cr | +11.3% |
| Earkart Limited | ₹151 Cr | 27.6 | — | ₹0 Cr | -54.3% |
| Avience Biomedicals Limited | ₹144 Cr | 11.7 | 27.86% | — | — |
Listed by market capitalisation. Ratios are shown for context only.
QMS Medical Allied Services Limited is trading at ₹170.50, with a market capitalisation of ₹330 Cr.
QMS Medical Allied Services Limited operates in the Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies space (Health Care Equipment > Medical Testing, Analyzing, and Diagnostic Equipment).
QMS Medical Allied Services Limited has a P/E of 32.4 and a return on equity of 12.29%.
QMS Medical Allied Services Limited is listed on the NSE under the symbol QMSMEDI.
QMS Medical Allied Services Limited's share price is up 80.0% over one year and up 27.0% over three months. Its 52-week range is ₹68.95 to ₹216.79.
In Q2 FY27, QMS Medical Allied Services Limited reported revenue of ₹53 Cr and net profit of ₹2 Cr, with basic EPS of ₹1.26 (consolidated, parsed from the company's exchange filing).
QMS Medical Allied Services Limited reported revenue of ₹53 Cr in Q2 FY27, up 17.5% from ₹45 Cr in Q2 FY26 and down 7.6% from ₹57 Cr in Q1 FY27.
Promoters held 68.11% of QMS Medical Allied Services Limited's shares as of Sept 2026, against 68.07% in Sept 2025 (+0.04 percentage points).
Data as of 19 Nov 2026. Descriptive market data only — not investment advice.